Shannon Rose

High Impact

Associate Professor

University of Arkansas for Medical Sciences

faculty

33 h-index 91 pubs 5,026 cited

Research Areas

Autism Spectrum Disorder Research Mitochondrial Function and Pathology Epigenetics and DNA Methylation Metabolomics and Mass Spectrometry Studies Child and Adolescent Health MicroRNA in disease regulation Obesity Mental Health Research Topics

Links

ORCID Lab Website Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Shannon Rose's research program investigates the biological underpinnings of neurodevelopmental disorders, with a particular focus on autism spectrum disorder (ASD) and early childhood obesity. Her work examines how factors such as mitochondrial function, redox balance, and epigenetic modifications like DNA methylation may contribute to the development and manifestation of these conditions. Rose has explored the role of microRNAs in immunomodulation within ASD and has analyzed integrated microRNA-mRNA expression profiles to identify novel molecular targets and networks associated with ASD.

Her research also extends to understanding the physiological mediators of prenatal environmental influences on ASD. Rose has published on metabolomic signatures in ASD and has investigated the connections between metabolic disturbances and the development of early childhood obesity. Collaborations with researchers at the University of Arkansas for Medical Sciences, including Elisabet Børsheim, Craig Porter, Pritmohinder S. Gill, and Hari Eswaran, have contributed to her publication record.

Rose's scholarly contributions are reflected in her h-index of 33 and over 5,000 citations across 91 publications. She is recognized as a highly cited researcher and leads an active research group. Her work contributes to the broader fields of child and adolescent health, mental health research, and molecular biology.

Metrics

h-index: 33
Publications: 91
Citations: 5,026

Selected Publications

Mitochondrial respiratory function in human platelets: Influence of sample preparation, assay buffer, and instrumental platform (2025) DOI
Correlating maternal and cord-blood inflammatory markers and BDNF with human fetal brain activity recorded by magnetoencephalography: An exploratory study (2024) DOI
Platelets, inflammation, and purinergic receptors in chronic kidney disease (2024) DOI
Regulatory T cells and bioenergetics of peripheral blood mononuclear cells linked to pediatric obesity (2024) DOI
Correlation of fetal heart rate dynamics to inflammatory markers and brain-derived neurotrophic factor during pregnancy (2024) DOI
Circulating microRNA levels differ in the early stages of insulin resistance in prepubertal children with obesity (2022) DOI
Air Pollution and Maximum Temperature Are Associated with Neurodevelopmental Regressive Events in Autism Spectrum Disorder (2022) DOI
Metabolomic Signatures of Autism Spectrum Disorder (2022) DOI
Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder (2022) DOI
Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism (2022) DOI
Effect of excess weight and insulin resistance on DNA methylation in prepubertal children (2022) DOI
A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder (2022) DOI
Blood RNA Sequencing Confirms Upregulated BATF2 and FCGR1A Expression in Children with Autism Spectrum Disorder (2021) DOI
MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation (2021) DOI
Redox Imbalance and Methylation Disturbances in Early Childhood Obesity (2021) DOI